References
- Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG. Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst 2016; 108(11); PMID:27335052; http://dx.doi.org/10.1093/jnci/djw144
- Hennequin A, Derangere V, Boidot R, Apetoh L, Vincent J, Orry D, Fraisse J, Causeret S, Martin F, Arnould L, et al. Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients. Oncoimmunol 2016; 5(2):e1054598; PMID:27057426; http://dx.doi.org/10.1080/2162402X.2015.1054598
- Lundgren S, Berntsson J, Nodin B, Micke P, Jirstrom K. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer. J Ovarian Res 2016; 9:21; PMID:27048364; http://dx.doi.org/10.1186/s13048-016-0232-0
- Szekeres K, Koul R, Mauro J, Lloyd M, Johnson J, Blanck G. An Oct-1-based, feed-forward mechanism of apoptosis inhibited by co-culture with Raji B-cells: towards a model of the cancer cell/B-cell microenvironment. Exp Mol Pathol 2014; 97(3):585-9; PMID:25236570; http://dx.doi.org/10.1016/j.yexmp.2014.09.010
- Gill TR, Samy MD, Butler SN, Mauro JA, Sexton WJ, Blanck G. Detection of Productively Rearranged TcR-α V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells. Cancer Inform 2016; 15:23-8; PMID:26966347
- Brown SD, Raeburn LA, Holt RA. Profiling tissue-resident T cell repertoires by RNA sequencing. Genome Med 2015; 7(1):125; PMID:26620832; http://dx.doi.org/10.1186/s13073-015-0248-x
- Butler SN, Blanck G. Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGA. Cell Tissue Res 2016; 363(2):491-6; PMID:26293619; http://dx.doi.org/10.1007/s00441-015-2261-1
- Paciello G, Acquaviva A, Pighi C, Ferrarini A, Macii E, Zamo A, Ficarra E. VDJSeq-Solver: in silico V(D)J recombination detection tool. PloS One 2015; 10(3):e0118192; PMID:25799103; http://dx.doi.org/10.1371/journal.pone.0118192
- Klarenbeek PL, Doorenspleet ME, Esveldt RE, van Schaik BD, Lardy N, van Kampen AH, Tak PP, Plenge RM, Baas F, de Bakker PI, et al. Somatic variation of T-Cell receptor genes strongly associate with HLA class restriction. PloS One 2015; 10(10):e0140815; PMID:26517366; http://dx.doi.org/10.1371/journal.pone.0140815
- Maletzki C, Schmidt F, Dirks WG, Schmitt M, Linnebacher M. Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers. Eur J Cancer 2013; 49(11):2587-95; PMID:23561850; http://dx.doi.org/10.1016/j.ejca.2013.02.035
- Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, Walsh LA, Postow MA, Wong P, Ho TS, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Eng J Med 2014; 371(23):2189-99; PMID:25409260; http://dx.doi.org/10.1056/NEJMoa1406498
- Westdorp H, Fennemann FL, Weren RD, Bisseling TM, Ligtenberg MJ, Figdor CG, Schreibelt G, Hoogerbrugge N, Wimmers F, de Vries IJ. Opportunities for immunotherapy in microsatellite instable colorectal cancer. Cancer Immunol Immunother 2016; 65(10):1249-59; PMID:27060000